Clarithromycin resistance among Helicobacter prlori strains isolated from children: Prevalence and study of mechanism of resistance by PCR-restriction fragment length polymorphism analysis

Journal of Clinical Microbiology

Volumn 41, Issue 1, 2003, Pages 486-488

  Alarcón, Teresa ^a   Vega, Alba E ^a,c   Domingo, Diego ^a   Martínez, Maria Josefa ^b   López Brea, Manuel ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b UNIVERSIDAD NACIONAL DE SAN LUIS   (Argentina)

^c HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; METRONIDAZOLE;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHILD; GENE MUTATION; HELICOBACTER PYLORI; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DRUG RESISTANCE; DRUG RESISTANCE, BACTERIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREVALENCE;

BACTERIA (MICROORGANISMS); HELICOBACTER; HELICOBACTER PYLORI; NEGIBACTERIA;

EID: 0037236769     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.1.486-488.2003     Document Type: Article

References (25)

1. Alarcón, T., D. Domingo, and M. López-Brea. 1999. Antibiotic resistance problems with Helicobacterpylori. Int. J. Antimicrob. Agents 12:19-26.
2. Alarcón, T., D. Domingo, N. Prieto, and M. López-Brea. 2000. Clarithromycin resistance stability in Helicobacterpylori: influence of the MIC and type of mutation in the 23S rRNA. J. Antimicrob. Chemother. 46:613-614.
3. Bontems, P., J. M. Devaster, L. Corvaglia, A. Dzsofi, C. Van der Borre, S. Goutier, J. P. Butzler, and S. Cadranel. 2001. Twelve year observation of primary and secondary antibiotic-resistant Helicobacter pylori strains in children. Pediatr. Infect. Dis. J. 20:1033-1038.
4. Broutet, N., S. Tchamgoné, E. Pereira, and F. Mégraud. 2000. Risk factors for failure of Helicobacter pylori eradication therapy, p. 601-607. In R. H. Hunt and G. N. J. Tytgat (ed.), Helicobacter pylori: basic mechanisms to clinical cure 2000. Kluwer Academic Publishers and Axcan Pharma, Dordrecht, The Netherlands.
5. Domingo, D., T. Alarcón, J. C. Sanz, I. Sánchez, and M. López-Brea. 1998. High frequency of mutations at position 2144 of 23S rRNA gene in clarithromycin-resistant Helicobacter pylori strains isolated in Spain. J. Antimicrob. Chemother. 41:573-574.
6. Drumm, B., S. Koletzko, and G. Oderda. 2000. H. pylori infection in children: a consensus statement. European Pediatric Task Force on H. pylori. J. Pediatr. Gastroenterol. Nutr. 30:207-213.
7. Dunn, B. E., H. Cohen, and M. J. Blaser. 1997. Helicobacter pylori. Clin. Microbiol. Rev. 10:720-741.
8. Dzierzanowska-Fangrat, K., E. Rozynek, P. Jozwiak, D. Celinska-Cedro, K. Madalinski, and D. Dzierzanowska. 2001. Primary resistance to clarithromycin in clinical strains of Helicobacter pylori isolated from children in Poland. Int. J. Antimicrob. Agents 18:387-390.
9. Glupczynski, Y., F. Megraud, M. López-Brea, and L P. Andersen. 2001. European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur. J. Clin. Microbiol. Infect. Dis. 20:820-823.
10. Granizo, J. J., L. Aguilar, J. Casal, C. García Rey, R. Dal-Re, and F. Baquero. 2000. Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and beta-lactam consumption in Spain (1979-1997). J. Antimicrob. Chemother. 46:767-773.
11. Granizo, J. J., L. Aguilar, J. Casal, R. Dal-Re, and F. Baquero. 2000. Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997). J. Antimicrob. Chemother. 46:959-964.
12. Kalach, N., M. Bergeret, P. H. Benhamou, C. Dupont, and J. Raymond. 2001. High levels of resistance to metronidazole and clarithromycin in Helicobacter pylori strains in children. J. Clin. Microbiol. 39:394-397.
13. Kalach, N., P. H. Benhamou, F. Campeotto, M. Bergeret, C. Dupont, and J. Raymond. 2001. Clarithromycin resistance and eradication of Helicobacter pylori in children. Antimicrob. Agents Chemother. 45:2134-2135.
14. Kato, S., S. Fujimura, H. Udagawa, T. Shimizu, S. Maisawa, K. Ozawa, and K. Iinuma, 2002. Antibiotic resistance of Helicobacter pylori strains in Japanese children. J. Clin. Microbiol. 40:649-653.
15. López-Brea, M., M.J. Martínez, D. Domingo, and T. Alarcón. 2001. A 9-year study of clarithromycin and metronidazole resistance in Helicobacterpylori from Spanish children. J. Antimicrob. Chemother. 48:295-297.
16. Megraud, F. 1997. Resistance of Helicobacter pylori to antibiotics. Aliment. Pharmacol. Ther. 11(Suppl. 1):43-53.
17. NCCLS. 2000. Performance standards for antimicrobial susceptibility testing. Tenth informational supplement (aerobic dilution). NCCLS document M100-S10 (M7). NCCLS, Wayne, Pa.
18. Pina, M., A. Occhialini, L. Monteiro, H.-P. Doermann, and F. Megraud. 1998. Detection of point mutations associated with resistance of Helicobacter pylori to clarithromycin by hybridization in liquid phase. J. Clin. Microbiol. 36:3285-3290.
19. Ruiz Bremón, A., M. Ruiz-Tovar, B. Pérez Gorricho, P. Díaz de Torres, and R. López Rodríguez. 2000. Non-hospital consumption of antibiotics in Spain: 1987-1997. J. Antimicrob. Chemother. 45:395-400.
20. Stone, G. G., D. Shortridge, J. Versalovic, J. Beyer, R. K. Flamm, D. Y. Graham, A. T. Ghoneim, and K. Tanaka. 1997. A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori. Antimicrob. Agents Chemother. 41:712-714.
21. Torres, J., M. Camorlinga-Ponce, G. Pérez-Pérez, A. Madrazo de la Garza, M. Dehesa, G. Gonzalez-Valencia, and O. Muñoz. 2001. Increasing multidrug resistance in Helicobacter pylori strains isolated from children and adults in Mexico. J. Clin. Microbiol. 39:2677-2680.
22. Unge, P. 1998. Antimicrobial treatment of Helicobacter pylori infection - a pooled efficacy analysis of eradication therapies. Eur. J. Surg. 582(Suppl.):16-26.
23. Versalovic, J., D. Shortridge, K. Kibler, M. V. Griffy, J. Beyer, R. K. Flamm, S. K. Tanaka, D. Graham, and M. F. Go. 1996. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob. Agents Chemother. 40:477-480.
24. World Health Organization. 1994. Infection with Helicobacter pylori. IARC Monogr. Eval. Carcinog. Risks Hum. 61:177-240.
25. Yang, Y. J., J. C. Yang, Y. M. Jeng, M. H. Chang, and Y. H. Ni. 2001. Prevalence and rapid identification of clarithromycin-resistant Helicobacter pylori isolates in children. Pediatr. Infect. Dis. J. 20:662-666.